Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 1;89(1):141-7.
doi: 10.1016/j.bcp.2014.02.006. Epub 2014 Feb 19.

Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide

Affiliations

Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide

Lisbeth K Siddens et al. Biochem Pharmacol. .

Abstract

Flavin-containing monooxygenase (FMO) oxygenates drugs/xenobiotics containing a soft nucleophile through a C4a hydroperoxy-FAD intermediate. Human FMOs 1, 2 and 3, expressed in Sf9 insect microsomes, released 30-50% of O₂ consumed as H₂O₂ upon addition of NADPH. Addition of substrate had little effect on H₂O₂ production. Two common FMO2 (the major isoform in the lung) genetic polymorphisms, S195L and N413K, were examined for generation of H₂O₂. FMO2 S195L exhibited higher "leakage", producing much greater amounts of H₂O₂, than ancestral FMO2 (FMO2.1) or the N413K variant. S195L was distinct in that H₂O₂ generation was much higher in the absence of substrate. Addition of superoxide dismutase did not impact H₂O₂ release. Catalase did not reduce levels of H₂O₂ with either FMO2.1 or FMO3 but inhibited H₂O₂ generated by FMO2 allelic variants N413K and S195L. These data are consistent with FMO molecular models. S195L resides in the GxGxSG/A NADP(+) binding motif, in which serine is highly conserved (76/89 known FMOs). We hypothesize that FMO, especially allelic variants such as FMO2 S195L, may enhance the toxicity of xenobiotics such as thioureas/thiocarbamides both by generation of sulfenic and sulfinic acid metabolites and enhanced release of reactive oxygen species (ROS) in the form of H₂O₂.

Keywords: Flavin-containing monooxygenase; Genetic polymorphism; Hydrogen peroxide; Oxidative stress; Pulmonary FMO2.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Structure of FAD during the Catalytic Cycle of Flavin-Containing Monooxygenases
Mammalian FMO and prokaryotic analogs have a catalytic cycle which first involves a rapid reduction by NADPH followed by binding of molecular oxygen and formation of the stable C4a-hydroperoxyflavin intermediate. This activated FAD was originally likened to a “cocked gun” by the late Dr. Henry Kamin, capable of reacting with any soft nucleophile (S) gaining proximity to this site. A nucleophilic attack by the substrate yielded an oxygenated product (S-O). The second atom of oxygen is then released as H2O and the final step in the cycle is the release of NADP+. The breakdown of the hydroxy-FAD pseudo base and release of NADP+ are the slowest steps in the catalytic cycle and determine FMO turnover rate. Uncoupling (dashed line) with release of H2O2 is promoted if NADP+ binding is compromised. This figure was taken from Alfieri et al., [37] with permission. Alfieri et al., [34] “Revealing the Moonlighting Role of NADP in the Structure of a Flavin-Containing Monooxygenase”, Proceedings of the National Academy of Sciences, U.S.A. 105(18):6572-77. Reprinted with permission.
Figure 2
Figure 2
Figure 2A. H2O2 generation (closed symbols) and O2 uptake (open symbols) monitored with an Apollo 4000 Radical Ion Analyzer in Sf9 microsomes from baculovirus expressed hFMO1 (diamonds), hFMO2.1(triangles), hFMO3 (squares) with ETU substrate (50 μM), and hFMO2.1 without substrate (circles) at pH 7.4, 37°C. Substrate was added after a 5 minute pre-incubation with 1 mM NADPH. Figure 2B. H2O2 yield as a percent of O2 consumption by human FMO1 (diamonds), FMO2.1 (triangles) and FMO3 (squares) over an incubation time of 60 minutes.
Figure 3
Figure 3
A comparison of the time-dependent production of H2O2 using two methods, Amplex Red assay (top) and the Apollo dual-electrode instrument (bottom). The incubations were performed as described in Materials and Methods at pH 7.4, 37°C in the absence of substrate.
Figure 4
Figure 4
Top panel: O2 consumption with time by FMO2.1, (open squares) and the N413K allelic variant (open triangles) and H2O2 production (closed symbols). ETU (50 μM) was added following a 5 minute pre-incubation with 1 mM NADPH and enzyme as described in Materials and Methods. Bottom panel: the percent yield of H2O2 as a function of O2 consumption over time is depicted for FMO2.1 (closed squares) and for the N413K allelic variant (closed triangles).
Figure 5
Figure 5
H2O2 production by human FMO2.1, the N413K and S195L FMO2 allelic variants and FMO3. Enzymes were incubated for 30 minutes at pH 7.4, 37°C, in the absence (open bars) or presence (solid gray bars) of 75 μM ethionamide. Catalase was added to enzymes in the absence (hatched bars) or presence (solid black bars) of ethionamide. The yield of H2O2 was determined by the Amplex Red assay. Note: hFMO3 was measured only in the presence of substrate ± catalase.
Figure 6
Figure 6
A. The yield of H2O2 with FMO2 S195L over a 20 minute incubation (pH 7.4, 37°C) was determined with the Apollo 4000 H2O2 electrode in the absence (squares) or presence of 100 μM ETU (circles) or 100 μM MTS (diamonds). The results were compared to H2O2 production by ancestral FMO2.1 in the absence of substrate (triangles). The assay was performed with 0.1 mM NADP+ and an NADPH-generating system as described in Materials and Methods. B. The yield of H2O2 by the FMO2 S195L allelic variant measured with an Apollo electrode over a 20 minute incubation with 1 mM NADPH (pH 7.4, 37°C and no NADPH-generating system). The greatest rate of H2O2 production was seen in the absence of substrate and with 0.2 μM SOD (filled triangles) followed by conditions with no substrate or SOD (open triangles). The addition of 1 mM glutathione in the absence of substrate (circles) markedly reduced the yield of H2O2. The yield of H2O2 over time in the presence of 50 μM ETU (inset) was equivalent in the presence (dotted line) or absence (solid line) of SOD.
Figure 6
Figure 6
A. The yield of H2O2 with FMO2 S195L over a 20 minute incubation (pH 7.4, 37°C) was determined with the Apollo 4000 H2O2 electrode in the absence (squares) or presence of 100 μM ETU (circles) or 100 μM MTS (diamonds). The results were compared to H2O2 production by ancestral FMO2.1 in the absence of substrate (triangles). The assay was performed with 0.1 mM NADP+ and an NADPH-generating system as described in Materials and Methods. B. The yield of H2O2 by the FMO2 S195L allelic variant measured with an Apollo electrode over a 20 minute incubation with 1 mM NADPH (pH 7.4, 37°C and no NADPH-generating system). The greatest rate of H2O2 production was seen in the absence of substrate and with 0.2 μM SOD (filled triangles) followed by conditions with no substrate or SOD (open triangles). The addition of 1 mM glutathione in the absence of substrate (circles) markedly reduced the yield of H2O2. The yield of H2O2 over time in the presence of 50 μM ETU (inset) was equivalent in the presence (dotted line) or absence (solid line) of SOD.
Figure 7
Figure 7
H2O2 production in rat CYP3A2 supersomes (0.1 nmol containing cDNA expressed rat NADPH CYP oxidoreductase (NOR) 2.8 μmol/(min × mg protein)) incubated for 60 min with benzphetamine (200 μM). Enzyme and NADPH (1 mM) were pre-incubated in 100 mM PBS, pH 7.4 at 37°C for 2 minutes, substrate added at T = 0.
Figure 8
Figure 8
Baseline H2O2 generated with no substrate in control Sf9 microsomes (open circles) compared to CYP3A2 (closed circles), FMO2.1 (closed triangles), FMO1 (closed diamonds) and FMO3 (closed squares) Sf9 expressed microsomes.
Figure 9
Figure 9
Comparison of H2O2 generated in two separate batches of Sf9 expressed microsomes using the Apollo 4000 Radical Ion Analyzer, FMO2.1 (squares) and N413K variant (triangles), incubated with ETU (50 μM) at pH 7.4, 37°C and S195L variant (circles) with no substrate at pH 7.4, 37°C (inset).

Similar articles

Cited by

References

    1. Cashman JR, Zhang J. Human flavin-containing monooxygenases. Annual Review of Pharmacology and Toxicology. 2006;46:65–100. - PubMed
    1. Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacology and Therapeutics. 2005;106:357–387. - PMC - PubMed
    1. Yeung CK, Lang DH, Thummel KE, Rettie AE. Immunoquantitation of FMO1 in human liver, kidney, and intestine. Drug Metabolism and Disposition. 2000;28:1107–1111. - PubMed
    1. Zhang J, Cashman JR. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metabolism and Disposition. 2006;34:19–26. - PubMed
    1. Dolphin CT, Beckett DJ, Janmohamed A, Cullingford TE, Smith RL, Shephard EA, Phillips IR. The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not other primates, encodes a truncated nonfunctional protein. The Journal of Biological Chemistry. 1998;273:30599–30607. - PubMed

Publication types

Substances